Last Update

Dr.
Richard A. Guarino

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Richard Guarino is President of Oxford Pharmaceuticals, Inc., and was the former CEO of Oxford Research International Corp.He is the editor of Informa Healthcare's Fourth Edition of New Drug Approval Process, the first book to guide and recommend ways to expedite global new drug approval processes while also following meeting federal and industry requirements.Dr. Guarino is a member of the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Columbus Foundation, Drug Information Association, Association of Clinical Research Professionals, and the Academy of Pharmaceutical Physicians and Investigators.

Richard A. Guarino, M.D. is President of Oxford Pharmaceutical Resources, Inc. a consulting organization specializing in the planning, implementing and submitting of INDs, NDAs and CTDs.Dr. Guarino also has 25 years of experience in new drug applications, in marketing launches, advertising, and FDA liaison.

Dr. Guarino was formerly the President and CEO of Oxford Research International Corp. one of the largest CROs in the United States.Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc., now Novartis, and held the position of Vice President/Medical Director at Revlon Healthcare Group.He has been acclaimed for his book, New Drug Approval Process, now in its 4th edition.It is the first book ever written to guide and recommend ways to expedite global new drug approval process while following all the requirements of the Code of Federal Regulations and EU Directives.

Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Columbus Foundation, Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).

Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Clinical and Regulatory Organization specializing in the planning, implementing and submitting INDs, NDAs, in the CTDs format.Dr, Guarino has 35 years of experience in new drug applications, marketing launches, pharmaceutical and product advertising, and FDA Liaison.He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States.Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group.He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition.
It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines.

Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).

Dr. Richard A. Guarino is President of Oxford Pharmaceutical Resources, Inc., a Consulting Clinical and Regulatory Organization specializing in the planning, implementing and submitting INDs, NDAs, in the CTDs format.Dr, Guarino has 35 years of experience in new drug applications, marketing launches, pharmaceutical and product advertising, and FDA Liaison.He was formerly the President and CEO of Oxford Research International Corp. one of the largest CRO's in the United States.Besides serving as an adjunct professor at Fairleigh Dickinson University, he was a former Director of Clinical Research at Sandoz Pharmaceutical Inc, (Novartis) and held the position of Vice President/Medical Director at Revlon Healthcare Group.He has been acclaimed for his book, New Drug Approval Process, now in its 5th edition.
It is the first book ever written to guide and recommend ways to expedite the new drug approval process while following all the requirements of the US Code of Federal Regulations, EU Directives and ICH Guidelines.

Dr. Guarino is a member of many professional societies and associations including the New Jersey and New York Academies of Medicine, The Royal Society of Medicine, the Columbus Citizens Foundation, the Presidential Advisory Cabinet at Fairleigh Dickinson University, the Lupus Erythematosus Foundation, the Cystic Fibrosis Foundation and the Sovereign Military Hospitaller Order of Saint John of Jerusalem of Rhodes and of Malta American Association, USA Drug Information Association (DIA), Association of Clinical Research Professionals (ACRP), and Academy of Pharmaceutical Physicians and Investigators (APPI).

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Thank You for Downloading!

1. DownloadZoomInfo Grow

2. Run InstallationWizard

3. Check your inbox to Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.